share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Feb 16 21:06

Gainers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 25.2% to $2.73 during Friday's pre-market session. The company's market cap stands at $1.5 million.
  • MediciNova (NASDAQ:MNOV) stock increased by 17.77% to $1.59. The market value of their outstanding shares is at $77.9 million. As per the press release, Q4 earnings came out yesterday.
  • Sarepta Therapeutics (NASDAQ:SRPT) shares moved upwards by 14.5% to $143.0. The market value of their outstanding shares is at $13.3 billion.
  • Ikena Oncology (NASDAQ:IKNA) shares rose 12.32% to $1.64. The company's market cap stands at $79.1 million.
  • Sientra (NASDAQ:SIEN) stock increased by 11.4% to $0.38. The company's market cap stands at $4.5 million.
  • Artivion (NYSE:AORT) stock increased by 10.86% to $20.0. The market value of their outstanding shares is at $820.9 million. As per the news, the Q4 earnings report came out yesterday.

Losers

  • Inventiva (NASDAQ:IVA) shares decreased by 8.6% to $3.6 during Friday's pre-market session. The company's market cap stands at $185.9 million.
  • T2 Biosystems (NASDAQ:TTOO) shares declined by 7.67% to $5.9. The company's market cap stands at $23.8 million. As per the press release, Q4 earnings came out yesterday.
  • Healthcare Triangle (NASDAQ:HCTI) shares fell 7.66% to $2.51. The market value of their outstanding shares is at $10.8 million.
  • Hepion Pharmaceuticals (NASDAQ:HEPA) shares fell 7.41% to $2.5. The market value of their outstanding shares is at $10.8 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock decreased by 7.31% to $1.65. The company's market cap stands at $34.8 million.
  • AMN Healthcare Services (NYSE:AMN) shares fell 7.26% to $72.0. The market value of their outstanding shares is at $2.7 billion. The company's, Q4 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment